The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight
The SCI treatment pipeline continues to expand, featuring candidates such as KP-100IT (Kringle Pharma), Neuro-Cells (Neuroplast), MT-3921 (Mitsubishi Tanabe Pharma…